BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19822356)

  • 1. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
    Cole LA; Muller CY
    Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".
    Seckl MJ; Savage PM; Hancock BW; Berkowitz RS; Goldstein DP; Lurain JR; Schink JC; Cagayan FM; Golfier F; Ngan H; Wake N; Osborne R; Sasaki S; Charry RC; Wong LC; Sekharan PK; Djamhoer MA; Massuger L; Belfort P; Kim SJ; Lee C; Jung SG
    Gynecol Oncol; 2010 Jun; 117(3):505-6; author reply 506-7. PubMed ID: 20181383
    [No Abstract]   [Full Text] [Related]  

  • 3. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the editor with comments on article by Cole and Muller entitled "Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".
    Kohorn EI
    Gynecol Oncol; 2010 Jun; 117(3):505. PubMed ID: 20144843
    [No Abstract]   [Full Text] [Related]  

  • 5. USA hCG reference service, 10-year report.
    Cole LA; Laidler LL; Muller CY
    Clin Biochem; 2010 Aug; 43(12):1013-22. PubMed ID: 20493830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally-aggressive gestational trophoblastic neoplasms.
    Cole LA
    Gynecol Oncol; 2012 Apr; 125(1):145-50. PubMed ID: 22198244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate management of women with persistent low hCG results.
    Cole LA; Khanlian SA
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases.
    Cole LA
    Int J Gynecol Cancer; 2014 Nov; 24(9):1709-14. PubMed ID: 25275660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycosylated hCG, a review.
    Cole LA
    Placenta; 2010 Aug; 31(8):653-64. PubMed ID: 20619452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
    Cole LA; Kohorn E; Smith HO
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG.
    Cole LA; Dai D; Butler SA; Leslie KK; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):145-50. PubMed ID: 16631920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sweet or low: does hyperglycosylated hCG define a new clinical entity or reveal inadequate care?
    Singh DK; Lurain JR
    Gynecol Oncol; 2010 Jan; 116(1):1-2. PubMed ID: 19962037
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycosylated hCG: a variant with separate biological functions to regular hCG.
    Cole LA; Khanlian SA
    Mol Cell Endocrinol; 2007 Jan; 260-262():228-36. PubMed ID: 17081684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA; Khanlian SA; Muller CY
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.